These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6238928)

  • 1. In-vitro activity of norfloxacin against Enterobacteriaceae and Pseudomonas aeruginosa.
    García-Rodríguez JA; Gómez-García AC; Rodrigo N
    J Antimicrob Chemother; 1984 Aug; 14(2):192-3. PubMed ID: 6238928
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro sensitivity pattern of gram negative pathogens to nalidixic acid.
    Chitkara YK
    Indian J Pathol Bacteriol; 1969 Oct; 12(4):162-8. PubMed ID: 4990210
    [No Abstract]   [Full Text] [Related]  

  • 3. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
    Guimaraes MA; Noone P
    J Antimicrob Chemother; 1986 Jan; 17(1):63-7. PubMed ID: 2936708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents.
    Body BA; Fromtling RA; Shadomy S; Shadomy HJ
    Eur J Clin Microbiol; 1983 Jun; 2(3):230-4. PubMed ID: 6224678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic sensitivity of gram-negative bacilli isolated from lesions since 1965].
    Yamaji Y; Takahashi M; Miyanaga Y; Todome Y; Motoyama M
    Jpn J Antibiot; 1968 Feb; 21(1):25-33. PubMed ID: 4174373
    [No Abstract]   [Full Text] [Related]  

  • 6. Formaldehyde-resistance in Enterobacteriaceae and Pseudomonas aeruginosa: identification of resistance genes by DNA-hybridization.
    Wollmann A; Kaulfers PM
    Zentralbl Hyg Umweltmed; 1991 May; 191(5-6):449-56. PubMed ID: 1909132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of pefloxacin compared to other antibiotics.
    Yourassowsky E; Van der Linden MP; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():19-28. PubMed ID: 3086279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro emergence of Escherichia coli and Pseudomonas aeruginosa strains resistant to norfloxacin and nalidixic acid.
    Piffaretti JC; Demarta A; Leidi-Bulla L; Peduzzi R
    Eur J Clin Microbiol; 1983 Dec; 2(6):600-1. PubMed ID: 6230227
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
    Forsgren A
    Scand J Infect Dis; 1985; 17(1):91-4. PubMed ID: 3158070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.
    Esko E; Renkonen OV
    Scand J Infect Dis; 1985; 17(1):95-8. PubMed ID: 3158071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative theoretical activity of antibiotics on the main gram-negative bacilli].
    Monnier J; Bourse R; Moatti N; Suc C
    Pathol Biol (Paris); 1969 Oct; 17(19):817-24. PubMed ID: 4985138
    [No Abstract]   [Full Text] [Related]  

  • 12. [Susceptibility of clinical bacterial isolates to aztreonam].
    Murase M; Niiya T; Takeuchi N
    Jpn J Antibiot; 1987 Sep; 40(9):1698-706. PubMed ID: 3121888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottrad M; Stille W
    Eur J Clin Microbiol; 1983 Jun; 2(3):272-4. PubMed ID: 6224688
    [No Abstract]   [Full Text] [Related]  

  • 15. Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria.
    Atlas E; Clark H; Silverblatt F; Turck M
    Ann Intern Med; 1969 Apr; 70(4):713-21. PubMed ID: 4977045
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.
    Downs J; Andriole VT; Ryan JL
    Antimicrob Agents Chemother; 1982 Apr; 21(4):670-2. PubMed ID: 6211142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ofloxacin: in-vitro activity against clinical isolates.
    Grima P
    Chemioterapia; 1985 Dec; 4(6):434-5. PubMed ID: 3938347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
    Chin NX; Neu HC
    Chemotherapy; 1987; 33(3):183-8. PubMed ID: 3109815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.